We have also shown that TLR3 activation induces HNSCC cell migration, a process that can be hindered by inhibiting endogenous ligands, particularly with aspirin as an HMGB1 inhibitor. This evidence concerns the gene TLR3 and head and neck squamous cell carcinoma.